Literature DB >> 15735055

Contractile fatigue, muscle morphometry, and blood lactate in chronic obstructive pulmonary disease.

Didier Saey1, Annie Michaud, Annabelle Couillard, Claude H Côté, M Jeffery Mador, Pierre LeBlanc, Jean Jobin, François Maltais.   

Abstract

We hypothesized that patients with chronic obstructive pulmonary disease developing contractile fatigue of the quadriceps during cycle exercise may have characteristic metabolic and muscle features that could increase their susceptibility to fatigue, thus differentiating them from those who do not develop fatigue. We examined, in 32 patients, the fiber-type proportion, enzymatic activities, and capillary density in the vastus lateralis and the arterial blood lactate level during constant work-rate cycling exercise. Contractile fatigue was defined as a postexercise fall in quadriceps twitch force greater than 15% of resting values. Twenty-two patients developed contractile fatigue after exercise. No significant differences were found between fatiguers and non-fatiguers for the endurance time, fiber-type proportion, and oxidative enzyme activities. The lactate dehydrogenase activity was significantly higher (p < 0.05) and muscle capillarization significantly reduced in fatiguers (p < 0.05). Compared with non-fatiguers, the arterial lactate level during exercise was significantly higher in fatiguers (p < 0.001). A significant relationship was found between the fall in quadriceps twitch force and lactate dehydrogenase activity, capillary/fiber ratio, and blood lactate level. We conclude that changes in muscle enzymatic profile and capillarization with a greater reliance on glycolytic metabolism during exercise are associated with contractile fatigue in patients with chronic obstructive pulmonary disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15735055     DOI: 10.1164/rccm.200408-1005OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  32 in total

1.  Higher blood flow and circulating NO products offset high-altitude hypoxia among Tibetans.

Authors:  S C Erzurum; S Ghosh; A J Janocha; W Xu; S Bauer; N S Bryan; J Tejero; C Hemann; R Hille; D J Stuehr; M Feelisch; C M Beall
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-30       Impact factor: 11.205

2.  Heat therapy promotes the expression of angiogenic regulators in human skeletal muscle.

Authors:  Alisha M Kuhlenhoelter; Kyoungrae Kim; Dustin Neff; Yaohui Nie; A Nicole Blaize; Brett J Wong; Shihuan Kuang; Julianne Stout; Qifan Song; Timothy P Gavin; Bruno T Roseguini
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-06-29       Impact factor: 3.619

Review 3.  Molecular and biological pathways of skeletal muscle dysfunction in chronic obstructive pulmonary disease.

Authors:  Esther Barreiro; Joaquim Gea
Journal:  Chron Respir Dis       Date:  2016-04-06       Impact factor: 2.444

4.  Myricetin improves endurance capacity by inducing muscle fiber type conversion via miR-499.

Authors:  Luting Wu; Li Ran; Hedong Lang; Min Zhou; Li Yu; Long Yi; Jundong Zhu; Lei Liu; Mantian Mi
Journal:  Nutr Metab (Lond)       Date:  2019-05-02       Impact factor: 4.169

5.  Impact of pulmonary system limitations on locomotor muscle fatigue in patients with COPD.

Authors:  Markus Amann; Mark S Regan; Majd Kobitary; Marlowe W Eldridge; Urs Boutellier; David F Pegelow; Jerome A Dempsey
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-05-05       Impact factor: 3.619

6.  Influence of blood flow occlusion on the development of peripheral and central fatigue during small muscle mass handgrip exercise.

Authors:  R M Broxterman; J C Craig; J R Smith; S L Wilcox; C Jia; S Warren; T J Barstow
Journal:  J Physiol       Date:  2015-08-02       Impact factor: 5.182

7.  Locomotor and diaphragm muscle fatigue in endurance athletes performing time-trials of different durations.

Authors:  Thomas U Wüthrich; Elisabeth C Eberle; Christina M Spengler
Journal:  Eur J Appl Physiol       Date:  2014-04-29       Impact factor: 3.078

8.  Skeletal Muscle Dysfunction in Chronic Obstructive Pulmonary Disease. What We Know and Can Do for Our Patients.

Authors:  Ariel Jaitovich; Esther Barreiro
Journal:  Am J Respir Crit Care Med       Date:  2018-07-15       Impact factor: 21.405

9.  Quadriceps muscle strength in scoliosis.

Authors:  E B Swallow; E Barreiro; H Gosker; S A Sathyapala; F Sanchez; N S Hopkinson; J Moxham; A Schols; J Gea; M I Polkey
Journal:  Eur Respir J       Date:  2009-05-14       Impact factor: 16.671

Review 10.  Factors contributing to muscle wasting and dysfunction in COPD patients.

Authors:  Rob C I Wüst; Hans Degens
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.